Enovis Corp Payment for Contingent Consideration Liability, Financing Activities
Enovis Corp (ENOV) reported Payment for Contingent Consideration Liability, Financing Activities of $49.22 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities · last filed 2026-02-26
- Enovis Corp payment for contingent consideration liability, financing activities for the quarter ending 2025-12-31 was $2.82M, a 100.28% increase year-over-year.
- Enovis Corp payment for contingent consideration liability, financing activities for the quarter ending 2025-10-03 was $21.00K, a 99.95% decline year-over-year.
- Enovis Corp payment for contingent consideration liability, financing activities for the quarter ending 2025-07-04 was -$1.00K, a 100.03% decline year-over-year.
- Enovis Corp payment for contingent consideration liability, financing activities for the quarter ending 2025-04-04 was $46.37M, a 1445.80% increase year-over-year.
- Enovis Corp payment for contingent consideration liability, financing activities for fiscal 2025 was $49.22M, a 7.60% decline from fiscal 2024.
- Enovis Corp payment for contingent consideration liability, financing activities for fiscal 2024 was $53.27M.
| Period end | Payment for Contingent Consideration Liability, Financing Activities 3 month | Payment for Contingent Consideration Liability, Financing Activities 6 month | Payment for Contingent Consideration Liability, Financing Activities 9 month | Payment for Contingent Consideration Liability, Financing Activities 12 month |
|---|---|---|---|---|
| 2025-12-31 | $2.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.85M derived: sum of 2 quarters · filed 2026-02-26 | $2.84M derived: sum of 3 quarters · filed 2026-02-26 | $49.22M 10-K · filed 2026-02-26 |
| 2025-10-03 | $21.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $20.00K derived: sum of 2 quarters · filed 2025-11-06 | $46.39M 10-Q · filed 2025-11-06 | $47.80M derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-07-04 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $46.37M 10-Q · filed 2025-08-07 | $47.78M derived: sum of 3 quarters · filed 2025-08-07 | $93.36M derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-04-04 | $46.37M 10-Q · filed 2025-05-08 | $47.78M derived: sum of 2 quarters · filed 2025-05-08 | $93.36M derived: sum of 3 quarters · filed 2025-05-08 | $96.64M derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-12-31 | $1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $46.99M derived: sum of 2 quarters · filed 2025-02-26 | $50.27M derived: sum of 3 quarters · filed 2025-02-26 | $53.27M 10-K · filed 2025-02-26 |
| 2024-09-27 | $45.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $48.86M derived: sum of 2 quarters · filed 2024-11-06 | $51.86M 10-Q · filed 2024-11-06 | |
| 2024-06-28 | $3.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $6.28M 10-Q · filed 2024-08-07 | ||
| 2024-03-29 | $3.00M 10-Q · filed 2024-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |